These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24465178)

  • 1. Nonindustry-sponsored preclinical studies on statins yield greater efficacy estimates than industry-sponsored studies: a meta-analysis.
    Krauth D; Anglemyer A; Philipps R; Bero L
    PLoS Biol; 2014 Jan; 12(1):e1001770. PubMed ID: 24465178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Industry sponsorship and publication bias among animal studies evaluating the effects of statins on atherosclerosis and bone outcomes: a meta-analysis.
    Anglemyer AT; Krauth D; Bero L
    BMC Med Res Methodol; 2015 Mar; 15():12. PubMed ID: 25880564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some salt with your statin, professor?
    Macleod M
    PLoS Biol; 2014 Jan; 12(1):e1001768. PubMed ID: 24465176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relationship between Risk of Bias Criteria, Research Outcomes, and Study Sponsorship in a Cohort of Preclinical Thiazolidinedione Animal Studies: A Meta-Analysis.
    Abdel-Sattar M; Krauth D; Anglemyer A; Bero L
    Evid Based Preclin Med; 2014 Apr; 1(1):11-20. PubMed ID: 25642330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Industry sponsorship and research outcome.
    Lundh A; Sismondo S; Lexchin J; Busuioc OA; Bero L
    Cochrane Database Syst Rev; 2012 Dec; 12():MR000033. PubMed ID: 23235689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Industry sponsorship and research outcome.
    Lundh A; Lexchin J; Mintzes B; Schroll JB; Bero L
    Cochrane Database Syst Rev; 2017 Feb; 2(2):MR000033. PubMed ID: 28207928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between study sponsorship, risks of bias, and research outcomes in atrazine exposure studies conducted in non-human animals: Systematic review and meta-analysis.
    Bero L; Anglemyer A; Vesterinen H; Krauth D
    Environ Int; 2016; 92-93():597-604. PubMed ID: 26694022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others.
    Bero L; Oostvogel F; Bacchetti P; Lee K
    PLoS Med; 2007 Jun; 4(6):e184. PubMed ID: 17550302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Industry sponsorship bias in research findings: a network meta-analysis of LDL cholesterol reduction in randomised trials of statins.
    Naci H; Dias S; Ades AE
    BMJ; 2014 Oct; 349():g5741. PubMed ID: 25281681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Industry sponsorship and research outcome: systematic review with meta-analysis.
    Lundh A; Lexchin J; Mintzes B; Schroll JB; Bero L
    Intensive Care Med; 2018 Oct; 44(10):1603-1612. PubMed ID: 30132025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Industry Sponsorship With Outcomes of Nutrition Studies: A Systematic Review and Meta-analysis.
    Chartres N; Fabbri A; Bero LA
    JAMA Intern Med; 2016 Dec; 176(12):1769-1777. PubMed ID: 27802480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When are statins cost-effective in cardiovascular prevention? A systematic review of sponsorship bias and conclusions in economic evaluations of statins.
    Catalá-López F; Sanfélix-Gimeno G; Ridao M; Peiró S
    PLoS One; 2013; 8(7):e69462. PubMed ID: 23861972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of conflict of interest in economic analyses of new drugs used in oncology.
    Friedberg M; Saffran B; Stinson TJ; Nelson W; Bennett CL
    JAMA; 1999 Oct; 282(15):1453-7. PubMed ID: 10535436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of industry sponsorship on the acceptance of abstracts and their publication.
    McLennan M; Leong FC; Steele A; Harris J
    Am J Obstet Gynecol; 2008 May; 198(5):579.e1-4. PubMed ID: 18455539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. If the Facts Were Not Untruths, Their Implications Were: Sponsorship Bias and Misleading Communication.
    Steel D
    Kennedy Inst Ethics J; 2018; 28(2):119-144. PubMed ID: 30100597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sponsors' participation in conduct and reporting of industry trials: a descriptive study.
    Lundh A; Krogsbøll LT; Gøtzsche PC
    Trials; 2012 Aug; 13():146. PubMed ID: 22920226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating solutions to sponsorship bias.
    Doucet M; Sismondo S
    J Med Ethics; 2008 Aug; 34(8):627-30. PubMed ID: 18667655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis.
    Fu R; Selph S; McDonagh M; Peterson K; Tiwari A; Chou R; Helfand M
    Ann Intern Med; 2013 Jun; 158(12):890-902. PubMed ID: 23778906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of sponsorship bias in economic studies of antidepressants.
    Baker CB; Johnsrud MT; Crismon ML; Rosenheck RA; Woods SW
    Br J Psychiatry; 2003 Dec; 183():498-506. PubMed ID: 14645020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between Research Outcomes and Risk of Bias, Study Sponsorship, and Author Financial Conflicts of Interest in Reviews of the Effects of Artificially Sweetened Beverages on Weight Outcomes: A Systematic Review of Reviews.
    Mandrioli D; Kearns CE; Bero LA
    PLoS One; 2016; 11(9):e0162198. PubMed ID: 27606602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.